Trial Profile
Efficacy and safety of telaprevir-based antiviral treatment for elderly patients with hepatitis C virus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 27 Nov 2015 New trial record